RESUMO
The most prevalent malignancy among women is breast cancer. Phytochemicals and their derivatives are rapidly being recognized as possible cancer complementary therapies because they can modify signaling pathways that lead to cell cycle control or directly alter cell cycle regulatory molecules. The phytochemicals' poor bioavailability and short half-life make them unsuitable as anticancer drugs. Applying PLGA-PEG NPs improves their solubility and tolerance while also reducing drug adverse effects. According to the findings, combining anti-tumor phytochemicals can be more effective in regulating several signaling pathways linked to tumor cell development. The point of the study was to compare the anti-proliferative impacts of combined artemisinin and metformin on cell cycle arrest and expression of cyclin D1 and apoptotic genes (bcl-2, Bax, survivin, caspase-7, and caspase-3), and also hTERT genes in breast cancer cells. T-47D breast cancer cells were treated with different concentrations of metformin (MET) and artemisinin (ART) co-loaded in PLGA-PEG NPs and free form. The MTT test was applied to assess drug cytotoxicity in T47D cells. The cell cycle distribution was investigated using flow cytometry and the expression levels of cyclin D1, hTERT, Bax, bcl-2, caspase-3, and caspase-7, and survivin genes were then determined using real-time PCR. The findings of the MTT test and flow cytometry revealed that each state was cytotoxic to T47D cells in a time and dose-dependent pattern. Compared to various state of drugs (free and nano state, pure and combination state) Met-Art-PLGA/PEG NPs demonstrated the strongest anti-proliferative impact and considerably inhibited the development of T-47D cells; also, treatment with nano-formulated forms of Met-Art combination resulted in substantial downregulation of hTERT, Bcl-2, cyclin D1, survivin, and upregulation of caspase-3, caspase-7, and Bax, in the cells, as compared to the free forms, as indicated by real-time PCR findings. The findings suggested that combining an ART/MET-loaded PLGA-PEG NP-based therapy for breast cancer could significantly improve treatment effectiveness.
Assuntos
Compostos de Alquilmercúrio , Antineoplásicos , Artemisininas , Neoplasias da Mama , Carbanilidas , Compostos de Etilmercúrio , Compostos Heterocíclicos , Metformina , Nanopartículas , Compostos de Trimetilestanho , Antineoplásicos/química , Apoptose , Artemisininas/farmacologia , Artemisininas/uso terapêutico , Compostos de Benzalcônio/farmacologia , Compostos de Benzalcônio/uso terapêutico , Benzoflavonas/farmacologia , Benzoflavonas/uso terapêutico , Neoplasias da Mama/metabolismo , Carbanilidas/farmacologia , Carbanilidas/uso terapêutico , Caspase 3/genética , Caspase 7 , Linhagem Celular Tumoral , Proliferação de Células , Ciclina D1/genética , Ciclina D1/metabolismo , Ciclina D1/farmacologia , Compostos de Etilmercúrio/farmacologia , Compostos de Etilmercúrio/uso terapêutico , Feminino , Compostos Heterocíclicos/farmacologia , Humanos , Metformina/farmacologia , Metformina/uso terapêutico , Compostos de Metacolina , Nanopartículas/química , Oximas/farmacologia , Oximas/uso terapêutico , Plasmalogênios/farmacologia , Plasmalogênios/uso terapêutico , Compostos de Sulfonilureia/farmacologia , Compostos de Sulfonilureia/uso terapêutico , Survivina/farmacologia , Survivina/uso terapêutico , Compostos de Trimetilestanho/farmacologia , Proteína X Associada a bcl-2RESUMO
Methylmercury (MeHg) and Ethylmercury (EtHg) are toxic to the central nervous system. Human exposure to MeHg and EtHg results mainly from the consumption of contaminated fish and thimerosal-containing vaccines, respectively. The mechanisms underlying the toxicity of MeHg and EtHg are still elusive. Here, we compared the toxic effects of MeHg and EtHg in Saccharomyces cerevisiae (S. cerevisiae) emphasizing the involvement of oxidative stress and the identification of molecular targets from antioxidant pathways. Wild type and mutant strains with deleted genes for antioxidant defenses, namely: γ-glutamylcysteine synthetase, glutathione peroxidase, catalase, superoxide dismutase, mitochondrial peroxiredoxin, cytoplasmic thioredoxin, and redox transcription factor Yap1 were used to identify potential pathways and proteins from cell redox system targeted by MeHg and EtHg. MeHg and EtHg inhibited cell growth, decreased membrane integrity, and increased the granularity and production of reactive species (RS) in wild type yeast. The mutants were predominantly less tolerant of mercurial than wild type yeast. But, as the wild strain, mutants exhibited higher tolerance to MeHg than EtHg. Our results indicate the involvement of oxidative stress in the cytotoxicity of MeHg and EtHg and reinforce S. cerevisiae as a suitable model to explore the mechanisms of action of electrophilic toxicants.
Assuntos
Antioxidantes/farmacologia , Compostos de Etilmercúrio/farmacologia , Compostos de Metilmercúrio/farmacologia , Estresse Oxidativo/efeitos dos fármacos , Saccharomyces cerevisiae/efeitos dos fármacos , Oxirredução/efeitos dos fármacos , Saccharomyces cerevisiae/metabolismoRESUMO
Functions of the nervous system are supported by the flow of cerebrospinal fluid (CSF), which is driven by the ciliary beating of ventricular ependymal cells. The aim of the present study was to examine whether methylmercury (MeHg), a substance with potent neurotoxicity in humans, affects the ciliary movement. The effects of another organic mercury compound, ethylmercury (EtHg), were also assessed for comparison. Toxicity of MeHg or EtHg was evaluated by measuring alterations in the ciliary beat frequency of ependymal cells lining the third ventricle of mouse brain slices. The obtained results were: (1) Both MeHg and EtHg started to inhibit ciliary motility between 1 and 3µM, the reported threshold limit of MeHg in humans. (2) An abrupt increase was observed in the inhibitory curves from 3 to 6µM for MeHg and EtHg. (3) The "give-in" concentration, i.e., concentration at which the cilia lose the ability to recover, for MeHg and EtHg was 6µM and 12µM, respectively. (4) Ciliary beating was irreversibly halted by MeHg and EtHg at concentrations above 12µM and 30µM, respectively. (5) The estimated half-maximal inhibitory concentration (IC50) for MeHg and EtHg was 5.53µM and 5.80µM, respectively. Based on these findings, we conclude that: (a) Ependymal cell cilia movement in mice was inhibited by MeHg in a concentration-dependent manner around concentrations reported to cause poisoning in humans; EtHg inhibited ciliary motility to a less extent. (b) Inhibition of CSF flow by suppression of ciliary movement is suggested to be an additional route for MeHg poisoning in humans, especially in prenatal exposure than in adult exposure.
Assuntos
Cílios/efeitos dos fármacos , Epêndima/citologia , Compostos de Etilmercúrio/farmacologia , Compostos de Metilmercúrio/farmacologia , Animais , Encéfalo/citologia , Ventrículos Cerebrais/citologia , Relação Dose-Resposta a Droga , Técnicas In Vitro , Camundongos , Camundongos Endogâmicos ICR , Fatores de TempoRESUMO
Most fluorescent probes for the investigation of calcium signaling also detect zinc ions. Consequently, changes in the intracellular zinc concentration could be mistaken for calcium signals. Thimerosal (TMS) is used as a calcium-mobilizing agent and we analyzed the contribution of zinc ions to the signal observed with fluorescent calcium probes after TMS stimulation. Our findings show that the fluorescent signal in lymphocytes is entirely due to zinc release. Experiments in the T lymphocyte cell line Jurkat and primary human lymphocytes show that TMS and its active metabolite, ethyl mercury, cause an increase in signal intensity with probes designed for the detection of either calcium or zinc ions. The TMS/ethyl mercury-induced signal of the calcium probes Fluo-4 and FURA-2 was completely absent when the zinc chelator TPEN [N,N,N',N'-tetrakis-(2-pyridyl-methyl)ethylenediamine] was added. In contrast, the signal caused by thapsigargin-induced release of calcium from the endoplasmic reticulum was unaffected by TPEN. In light of these observations, zinc may also contribute to calcium signals caused by mercury-containing compounds other than TMS, and a potential involvement of zinc release in the immunomodulatory effects of these substances should be considered.
Assuntos
Sinalização do Cálcio/efeitos dos fármacos , Corantes Fluorescentes/metabolismo , Linfócitos/metabolismo , Timerosal/farmacologia , Zinco/farmacologia , Etilaminas/farmacologia , Compostos de Etilmercúrio/farmacologia , Humanos , Espaço Intracelular/efeitos dos fármacos , Espaço Intracelular/metabolismo , Íons , Células Jurkat , Piridinas , Pirimidinas/farmacologia , Salicilatos/farmacologia , Compostos de Sulfidrila/farmacologia , Tapsigargina/farmacologiaRESUMO
BACKGROUND: It has been hypothesized that early exposure to thimerosal, a mercury-containing preservative used in vaccines and immune globulin preparations, is associated with neuropsychological deficits in children. METHODS: We enrolled 1047 children between the ages of 7 and 10 years and administered standardized tests assessing 42 neuropsychological outcomes. (We did not assess autism-spectrum disorders.) Exposure to mercury from thimerosal was determined from computerized immunization records, medical records, personal immunization records, and parent interviews. Information on potential confounding factors was obtained from the interviews and medical charts. We assessed the association between current neuropsychological performance and exposure to mercury during the prenatal period, the neonatal period (birth to 28 days), and the first 7 months of life. RESULTS: Among the 42 neuropsychological outcomes, we detected only a few significant associations with exposure to mercury from thimerosal. The detected associations were small and almost equally divided between positive and negative effects. Higher prenatal mercury exposure was associated with better performance on one measure of language and poorer performance on one measure of attention and executive functioning. Increasing levels of mercury exposure from birth to 7 months were associated with better performance on one measure of fine motor coordination and on one measure of attention and executive functioning. Increasing mercury exposure from birth to 28 days was associated with poorer performance on one measure of speech articulation and better performance on one measure of fine motor coordination. CONCLUSIONS: Our study does not support a causal association between early exposure to mercury from thimerosal-containing vaccines and immune globulins and deficits in neuropsychological functioning at the age of 7 to 10 years.
Assuntos
Desenvolvimento Infantil/efeitos dos fármacos , Inteligência/efeitos dos fármacos , Conservantes Farmacêuticos/farmacologia , Timerosal/farmacologia , Criança , Deficiências do Desenvolvimento/induzido quimicamente , Deficiências do Desenvolvimento/epidemiologia , Deficiências do Desenvolvimento/prevenção & controle , Exposição Ambiental/análise , Compostos de Etilmercúrio/efeitos adversos , Compostos de Etilmercúrio/análise , Compostos de Etilmercúrio/farmacologia , Feminino , Humanos , Imunoglobulinas/administração & dosagem , Imunoglobulinas/química , Lactente , Recém-Nascido , Masculino , Testes Neuropsicológicos , Gravidez , Efeitos Tardios da Exposição Pré-Natal , Conservantes Farmacêuticos/efeitos adversos , Análise de Regressão , Timerosal/efeitos adversos , Vacinas/efeitos adversos , Vacinas/químicaRESUMO
Thimerosal, also known as thimersal, Merthrolate, or sodiumethyl-mercurithiosalicylate, is an organic mercurial compound that is used in a variety of commercial as well as biomedical applications. As a preservative, it is used in a number of vaccines and pharmaceutical products. Its active ingredient is ethylmercury. Both inorganic and organic mercurials are known to interfere with glutamate homeostasis. Brain glutamate is removed mainly by astrocytes from the extracellular fluid via high-affinity astroglial Na+-dependent excitatory amino acid transporters, glutamate/ aspartate transporter (GLAST) and glutamate transporter-1 (GLT-1). The effects of thimerosal on glutamate homeostasis have yet to be determined. As a first step in this process, we examined the effects of thimerosal on the transport of [3H]-d-aspartate, a nonmetabolizable glutamate analog, in Chinese hamster ovary (CHO) cells transfected with two glutamate transporter subtypes, GLAST (EAAT1) and GLT-1 (EAAT2). Additionally, studies were undertaken to determine the effects of thimerosal on mRNA and protein levels of these transporters. The results indicate that thimerosal treatment caused significant but selective changes in both glutamate transporter mRNA and protein expression in CHO cells. Thimerosal-mediated inhibition of glutamate transport in the CHO-K1 cell line DdB7 was more pronounced in the GLT-1-transfected cells compared with the GLAST- transfected cells. These studies suggest that thimerosal accumulation in the central nervous system might contribute to dysregulation of glutamate homeostasis.
Assuntos
Sistema X-AG de Transporte de Aminoácidos/genética , Compostos de Etilmercúrio/farmacologia , Transportador 2 de Aminoácido Excitatório/genética , Ácido Glutâmico/farmacocinética , Timerosal/farmacologia , Animais , Transporte Biológico , Northern Blotting , Western Blotting , Encéfalo/metabolismo , Células CHO , Linhagem Celular , Sistema Nervoso Central/efeitos dos fármacos , Cricetinae , DNA Complementar/metabolismo , Técnicas In Vitro , Conservantes Farmacêuticos/farmacologia , RNA Mensageiro/metabolismo , Fatores de Tempo , TransfecçãoRESUMO
Anti-thymocyte globulin (ATG), a horse antiserum to human thymus tissue, has been shown to induce granulocytic differentiation of the HL-60 human leukemia cell line. In this paper we describe the effect of ATG on leukemic blasts and its effect on other human leukemia cell lines in vitro. The in vitro differentiation effect of ATG was observed in blasts from two patients with leukemia and the human leukemia cell line K562. The differentiation effect of ATG was attributable to its preservative, thimerosal, separable from ATG by high pressure liquid chromatography or dialysis. Subsequent studies with thimerosal alone showed it to induce differentiation in leukemic blasts from three patients and the human leukemia cell lines U937, K562, and KG-1. The differentiation effect of thimerosal is blocked by a sulfhydryl-protective agent, dithiothreitol, suggesting that the mechanism of differentiation may be mediated via a sulfhydryl group-dependent process.
Assuntos
Soro Antilinfocitário/farmacologia , Compostos de Etilmercúrio/farmacologia , Hematopoese/efeitos dos fármacos , Células-Tronco Hematopoéticas/citologia , Timerosal/farmacologia , Células Tumorais Cultivadas/citologia , Soro Antilinfocitário/isolamento & purificação , Crise Blástica/patologia , Diferenciação Celular/efeitos dos fármacos , Linhagem Celular , Replicação do DNA/efeitos dos fármacos , Células-Tronco Hematopoéticas/efeitos dos fármacos , Hemoglobinas/biossíntese , Humanos , Leucemia/patologia , Timerosal/isolamento & purificação , Timidina/metabolismo , Células Tumorais Cultivadas/efeitos dos fármacosRESUMO
Only small amounts of leukotrienes could be detected by reverse-phase HPLC analysis after stimulation of human polymorphonuclear leukocytes (PMN) by the receptor agonist N-formyl-methionyl-leucyl-phenylalanine (fMLP). Preincubation of the cells with the organomercury compound thimerosal prior to fMLP-addition, however, resulted in the formation of significant amounts of 5-lipoxygenase derived metabolites. This effect was dose-dependent with respect both to fMLP and thimerosal. Thimerosal alone did neither lead to the formation of HPLC-detectable leukotrienes nor to the release of arachidonic acid in [1-14C]arachidonic acid prelabelled cells. The formation of leukotrienes by fMLP/thimerosal required extracellular Ca2+. Measurements of intracellular Ca2(+)-levels revealed that (i) thimerosal alone is able to release Ca2+ from internal stores and (ii) thimerosal causes a persistent accumulation of Ca2+ within the cells after stimulation by fMLP. We conclude that by the synergistic action of fMLP and thimerosal the Ca2(+)-levels exceed the threshold for phospholipase A2 activation resulting in the liberation of arachidonic acid and subsequently in the formation of 5-lipoxygenase products. Our results suggest that thimerosal may provide a model for leukotriene formation under pathophysiological conditions when SH-group oxidation leads to increased intracellular Ca2(+)-levels.
Assuntos
Cálcio/metabolismo , Compostos de Etilmercúrio/farmacologia , Leucotrieno B4/biossíntese , N-Formilmetionina Leucil-Fenilalanina/farmacologia , Neutrófilos/metabolismo , Timerosal/farmacologia , Araquidonato 5-Lipoxigenase/metabolismo , Ácido Araquidônico , Ácidos Araquidônicos/metabolismo , Sinergismo Farmacológico , Ácido Egtázico/farmacologia , Humanos , Inibidores de Lipoxigenase , Neutrófilos/efeitos dos fármacos , Fosfolipases A/antagonistas & inibidores , Fosfolipases A2RESUMO
The effect of the sulfhydryl (SH) group inhibitor ethylmercurithiosalicylate (thimerosal) on the function of human platelets was investigated. In contrast to known SH reagents such as p-chloromercuribenzoate or N-ethylmaleimide, thimerosal elicited both aggregation and [3H]serotonin release of washed human platelets at low micromolar concentrations (greater than or equal to 2 microM). Only a significant higher dose (greater than or equal to 15 microM) was effective when platelets were pretreated with the cyclooxygenase inhibitor aspirin, indicating an amplification of the proaggregatory effect of thimerosal by secondary prostaglandin (PG) endoperoxide and/or thromboxane (TX) formation. Consistent with this notion, thimerosal induced endogenous platelet arachidonic acid (20:4) metabolism which could be attributed to enhanced 20:4 liberation, presumably by activation of phospholipase A2. The latter effect was mediated by mobilization of intracellular calcium (Ca2+), and was not affected by removal of extracellular Ca2+. In the presence of aspirin, the thimerosal-induced Ca2+ elevation was completely reversed by dithiothreitol (DTT) which implicates SH groups in intracellular Ca2+ transport. In contrast to previous observations with other SH reagents, thimerosal had no effect on the inositoltrisphosphate (IP3)-mediated release or the sequestration (and/or extrusion) of intracellular Ca2+ following stimulation with thrombin, indicating an action on an as yet undefined CA2+ transport system.
Assuntos
Plaquetas/fisiologia , Cálcio/sangue , Compostos de Etilmercúrio/farmacologia , Agregação Plaquetária/efeitos dos fármacos , Endoperóxidos de Prostaglandina/sangue , Timerosal/farmacologia , Aspirina/farmacologia , Plaquetas/efeitos dos fármacos , Ácido Egtázico/farmacologia , Humanos , Técnicas In Vitro , Cinética , Fosfolipídeos/sangueRESUMO
Availability of the common precursor arachidonic acid represents the fundamental prerequisite of the cellular eicosanoid synthesis. The amount of free arachidonic acid is regulated not only by phospholipases, which liberate this polyunsaturated fatty acid from lipid pools, but also by the reacylating enzyme acylCoA:lysophosphatide acyltransferase. We have previously shown (Goppelt-Strübe, G., C.-F. Körner, G. Hausmann, D. Gemsa, and K. Resch. Control of Prostanoid Synthesis: Role of Reincorporation of Released Precursor Fatty Acids. Prostaglandins 32:373. 1986.) that the organic mercury compound thimerosal in murine peritoneal macrophages inhibits arachidonic acid reincorporation into cellular lipids, thereby leading to an enhanced prostanoid synthesis. In this report we show that the production of leukotriene C4 was also increased after the addition of thimerosal to mouse peritoneal macrophages in a time and dose dependent manner. Concomitantly, thimerosal led to a significant rise of the intracellular calcium concentration as measured by fura-2 fluorescence. Simultaneous addition of thimerosal and indomethacin or exogeneous arachidonic acid to the cells resulted in a synergistic enhancement of leukotriene C4 synthesis. On the other hand, another sulfhydryl group blocking agent, ethacrynic acid, was found to be ineffective in increasing leukotriene C4 levels even in combination with exogeneous arachidonic acid. Thimerosal therefore provides a helpful tool in studying the basic regulatory mechanisms of the cellular leukotriene synthesis.
Assuntos
Ácidos Araquidônicos/metabolismo , Compostos de Etilmercúrio/farmacologia , Macrófagos/metabolismo , Prostaglandinas/metabolismo , Timerosal/farmacologia , Tromboxanos/metabolismo , Animais , Ácido Araquidônico , Cálcio/metabolismo , Cromatografia Líquida de Alta Pressão , Ácido Etacrínico/farmacologia , Feminino , Indometacina/farmacologia , Masoprocol/farmacologia , Camundongos , Camundongos Endogâmicos , Radioimunoensaio , SRS-A/biossíntese , SRS-A/metabolismoRESUMO
We describe bacterial contamination of a 'Cialit'-preserved cartilage bank which continued after a variety of changes to the harvesting and preservation protocols during a 3-year prospective study. Our results emphasize the importance of adequate tissue bank microbiological screening. Alternative methods of tissue preservation should be considered.
Assuntos
Cialit/farmacologia , Compostos de Etilmercúrio/farmacologia , Preservação de Tecido/métodos , Bactérias/efeitos dos fármacos , Bactérias/isolamento & purificação , Cartilagem/microbiologia , Cartilagem/transplante , Humanos , Estudos Prospectivos , Bancos de Tecidos/normasRESUMO
The effects of ethylmercurithiosalicylate (thimerosal) on the transformation of arachidonic acid via the 5-lipoxygenase pathway in human leukocytes stimulated with the Ca-ionophore A23187 were studied. Thimerosal inhibited acyltransferase, 5-lipoxygenase and the omega-oxidation system of LTB4 in a concentration-dependent fashion which was characteristic for the individual metabolites. LTA4 hydrolase activity was not affected. The inhibitory effects of thimerosal occurred instantaneously. The effects of the drug were not influenced by the concentration of the stimulus Ca-ionophore A23187.
Assuntos
Ácidos Araquidônicos/metabolismo , Compostos de Etilmercúrio/farmacologia , Neutrófilos/efeitos dos fármacos , Timerosal/farmacologia , Aciltransferases/antagonistas & inibidores , Ácido Araquidônico , Calcimicina/farmacologia , Cromatografia Líquida de Alta Pressão , Humanos , Técnicas In Vitro , Inibidores de Lipoxigenase , Neutrófilos/metabolismoRESUMO
Our previous kinetic studies indicated that SH-modified myosin subfragment-1 A1 isozyme (S1(A1] contains at least two different types of active sites (Emoto, Y., Kawamura, T., & Tawada, K. (1985) J. Biochem. 98, 735-745). In those studies we have modified highly reactive SH-groups in S1(A1) with thimerosal. In this work, we separated the modified S1(A1) into two equimolar fractions by affinity chromatography with agarose-ADP. For the separation, Mg2+ in the elution buffer was indispensable. Although the two fractions appeared to have the same number of modified SH-groups per mol of S1, they had different enzymic and fluorescent properties. SH-modification with an excess of thimerosal for a much longer duration did not change any of the results: not the chromatographic profile, the properties of the two fractions, nor the number of modified SH-groups. Hence the two different populations were not generated by incomplete modification. After reduction with dithiothreitol, however, the differences between the two fractions disappeared. When we separately re-modified the reduced fractions and re-chromatographed them, in each case we again obtained two fractions, which had the same properties as the two fractions obtained from the original modification with thimerosal. These results demonstrate that the active site heterogeneity in SH-modified S1(A1) had no intrinsic origin in the unmodified S1: it was introduced by the SH-modification, but by an unknown mechanism(s) other than incomplete modification.
Assuntos
Adenosina Trifosfatases/isolamento & purificação , Compostos de Etilmercúrio/farmacologia , Miosinas/isolamento & purificação , Fragmentos de Peptídeos/isolamento & purificação , Timerosal/farmacologia , Adenosina Trifosfatases/metabolismo , Sítios de Ligação , Cromatografia de Afinidade , Ditiotreitol/farmacologia , Cinética , Subfragmentos de Miosina , Miosinas/metabolismo , Fragmentos de Peptídeos/metabolismo , Espectrometria de FluorescênciaRESUMO
El espectro de absorción de una solución con mertiolato y ácido desoxirribonucleico transformante de Haemophilus influenzae, fue igual al que se obtuvo al sumar sus dos espectros independientes. Después de dializar el mertiolato, el DNA mostró su espectro de absorción típico y su actividad transformantes fue igual al DNA testigo dializado que no había estado en presencia del mertiolato. Se describe un método nuevo para aislar el DNA transformante de H. influenzae que requirió: 1) lisis bacteriana con mertiolato, 2) despretinización con cloroformo: octanol, 3) preciptación del DNA con etanol frío, 4) eliminación del RNA por hidrólisis con ribonucleasa pancreática; 5) diálise y 6) conservación a - 70-C. el DNA transformante obtenido y purificado, después de la lisis con mertiolato de H. influenzae, tuvo un espectro de absorción típico con una lambda max entre 255 y 260 nm y una lambda min entre 230 y 235 nm. Los valores de E (P) a 260 y 230 nm fueron típicos de DNA nativo. La igualdad en la concentración de DNA determinada por el método espectrofotométrico o por su contenido en desorribosa, indicó la ausencia de cantidades significativas de RNA. La relación de absorbancia de 260 sobre 230 nm tuvo un valor alrededor de 2.2, sugiriendo que no había una concentración apreciable de proteínas. El DNA mostró una actividad transformante específica típica del ácido desoxirribonucleico transformante de H. influenzae
Assuntos
DNA Bacteriano/genética , Haemophilus influenzae/efeitos dos fármacos , Transformação Bacteriana , DNA Bacteriano/isolamento & purificação , Compostos de Etilmercúrio/farmacologia , Hidrólise , Timerosal/farmacologiaRESUMO
To assess ultrastructural alterations to the corneal endothelium, eye drops containing vehicle alone or vehicle plus 0.004% thimerosal with or without 0.1% disodium ethylenediaminetetraacetate (Na2EDTA) were administered hourly over a 2-day period to rabbit corneas in vivo. Twenty of the corneas received a 5-mm keratectomy that removed epithelium and superficial stroma and 10 corneas were left intact. The vehicle alone had no effect on the endothelium of normal corneas. Thimerosal drops with or without Na2EDTA caused some clarification of the cytoplasm and dilatation of the endoplasmic reticulum of endothelial cells. The mitochondria had dilated cristae and membrane condensations. After keratectomy and vehicle only drops, the central endothelium showed a marked increase in microvilli and mitochondrial changes. Addition of either thimerosal or thimerosal plus Na2EDTA resulted in a slight decrease in membrane activity but an increase in intracellular edema and dilatation and damage to organelles. The peripheral areas were less affected than the center. Although the endothelium was stressed, most changes were considered reversible.
Assuntos
Córnea/efeitos dos fármacos , Compostos de Etilmercúrio/farmacologia , Timerosal/farmacologia , Animais , Núcleo Celular/ultraestrutura , Córnea/ultraestrutura , Citoplasma/ultraestrutura , Endotélio/efeitos dos fármacos , Endotélio/ultraestrutura , Microscopia Eletrônica , Microscopia Eletrônica de Varredura , CoelhosRESUMO
The purpose of the present experiment was to look at the dissolution time in physiological sodium chloride (0.9% NaCl) and sodium sulfide (Na2S) of any mercury (Hg) contained in human auditory ossicles and cartilage after preservation in Cialit and Merthiolate. Both homograft tissues produced almost identical graph complexes. Under static conditions 10 micrograms Hg could be found in NaCl after 15 min, whereas there was complete demercurization after 3 min in Na2S. The dissolution time in NaCl subjected to constant stirring was about 10 min and was less than 1 min in Na2S. For the rapid elimination of Hg from auditory ossicles stored in preservatives containing Hg, our studies show that the use of a flowing solvent is advisable. Further, the extraction of Hg is quicker in sodium sulfide than in an isotonic solution of sodium chloride.
Assuntos
Cartilagem/análise , Cialit/farmacologia , Ossículos da Orelha/análise , Compostos de Etilmercúrio/farmacologia , Mercúrio , Sulfetos/farmacologia , Timerosal/farmacologia , Preservação de Tecido , Fenômenos Químicos , Química , Humanos , Indicadores e Reagentes , Mercúrio/isolamento & purificação , Cloreto de Sódio/farmacologiaRESUMO
Thimerosal stimulates the production of a labile, smooth-muscle-relaxing substance in native and cultured endothelial cells. This substance is not prostacyclin (or any other prostaglandin) but has properties similar to the EDRF released by ACh or bradykinin. The production of EDRF in response to thimerosal is slower in onset, and may involve biochemical mechanisms different from those stimulated by other endothelium-dependent relaxants. The above results suggest that inhibition of acyl-CoA:lysophosphatide acyltransferase (by interaction with thiol groups of the enzyme) is the mechanism underlying the thimerosal-induced EDRF production.
Assuntos
Produtos Biológicos/metabolismo , Compostos de Etilmercúrio/farmacologia , Timerosal/farmacologia , 1-Acilglicerofosfocolina O-Aciltransferase/antagonistas & inibidores , Animais , Aorta/efeitos dos fármacos , Aorta/metabolismo , Bovinos , Células Cultivadas , Endotélio/efeitos dos fármacos , Endotélio/metabolismo , Técnicas In Vitro , Óxido Nítrico , CoelhosRESUMO
The sulfhydryl reagent thimerosal, as well as acetylcholine and Ca2+-ionophore A23187, produced concentration-dependent relaxations of intact rabbit aortic strips. The ability of strips to relax in response to these agents was dependent on the presence of vascular endothelium. Purposely removing the endothelium led to a complete loss of the relaxation responses. Thimerosal was at least as efficacious as A23187 in inducing endothelium-dependent relaxations, but its relaxations developed much slower than those induced by A23187 or acetylcholine. A small concentration of thimerosal that had no appreciable effect by itself, potentiated the relaxing response to acetylcholine in endothelium-intact preparations. Endothelium-dependent relaxations induced by larger concentrations of thimerosal, as well as relaxations produced by acetylcholine, were inhibited by the antioxidant and lipoxygenase inhibitor nordihydroguaiaretic acid, by haemoglobin, and by the inhibitor of soluble guanylate cyclase methylene blue. Indomethacin had no effect on these relaxations. The thiol compounds glutathione, 2-mercaptoethanol and a low concentration of dithiothreitol prevented (and reversed) relaxations induced by thimerosal, but had little or no effect on ACh relaxations. A high concentration of dithiothreitol also markedly inhibited the ACh relaxation. These results are consistent with the hypothesis that thimerosal stimulates endothelial cells to produce a relaxing substance whose properties are similar or the same as those of the endothelium-derived relaxing factor (EDRF) released in response to acetylcholine or A23187. The biochemical mechanism by which thimerosal induces the formation and/or release of this relaxing substance is likely to be different from ACh.(ABSTRACT TRUNCATED AT 250 WORDS)
Assuntos
Compostos de Etilmercúrio/farmacologia , Músculo Liso Vascular/efeitos dos fármacos , Compostos de Sulfidrila/farmacologia , Timerosal/farmacologia , Vasodilatadores , Acetilcolina/farmacologia , Animais , Calcimicina/farmacologia , Endotélio/fisiologia , Feminino , Técnicas In Vitro , Masculino , Relaxamento Muscular/efeitos dos fármacos , Óxido Nítrico , Norepinefrina/farmacologia , CoelhosRESUMO
Two competitive inhibitors of beta-D-galactosidase activity, namely, 2,6-anhydro-S-[ethylmercury(II)]-1-thio-D-glycero-L-manno-heptitol (4) and bis(2,6-anhydro-1-thio-D-glycero-L-manno-heptitol)mercury(II) (6), with inhibition constants of 8.0 X 10(-4) M and 1.9 X 10(-4) M, were synthesized. Compound 6 was incorporated into the crystalline enzyme by cocrystallization. The stoichiometry of the enzyme-inhibitor complex was 1:4, corresponding to one molecule of inhibitor per active site of the enzyme. Compound 4 was found to be unstable against X-ray irradiation, whereas compound 6 was submitted to X-rays for several days without any radiation damage.
Assuntos
Escherichia coli/enzimologia , Compostos de Etilmercúrio/síntese química , Galactosidases/antagonistas & inibidores , Álcoois Açúcares/síntese química , beta-Galactosidase/antagonistas & inibidores , Compostos de Alquilmercúrio/síntese química , Compostos de Alquilmercúrio/farmacologia , Compostos de Etilmercúrio/farmacologia , Indicadores e Reagentes , Cinética , Relação Estrutura-Atividade , Álcoois Açúcares/farmacologiaRESUMO
Treatment of the Na,K-ATPase enzyme, isolated from canine renal outer medulla, with thimerosal (ethylmercurithiosalicylate) resulted in significant inhibition of the overall Na,K-ATPase with only slight, if any, inhibition of the Na-ATPase and ATP:ADP exchange activities. The K-stimulated PNPPase activity was stimulated [see G. R. Henderson and A. Askari (1977) Arch. Biochem. Biophys. 182, 221-226]. Examination of the Na dependence of the ATPase and ATP:ADP exchange activities revealed an Na-independent, ouabain-sensitive activity that was inhibited by Na in the range 0-10 mM. At greater than or equal to 10 mM concentration of Na the treated and modified enzymes showed similar activities. The apparent affinity of the modified enzyme for ATP in the presence of 100 mM Na was the same as that of the untreated enzyme (0.2-0.3 microM). In the absence of Na, the modified enzyme hydrolyzed ATP with a relatively low affinity (about 120 microM). The enhancement of p-nitrophenylphosphatase (PNPPase) activity measured in the presence of K ions was due to the appearance of K-independent, ouabain-sensitive PNPP activity. The modification was without major affect on the apparent affinity of the enzyme for K ions in the PNPPase activity. Treatment of the thimerosal-modified enzyme with dithiothreitol removed (or greatly reduced) the cation-independent, ouabain-sensitive activities and the Na,K-ATPase activity returned. Modification of a set of enzyme -SH groups in the Na,K-ATPase enzyme made it able to hydrolyze ATP in the absence of Na ions and PNPP in the absence of K ions. The -SH groups modified by thimerosal are evidently critical to the major dephosphoenzyme conformational changes but are not involved in the major transport conformational change between phosphoenzymes.